PSY96 - COST-EFFECTIVENESS OF ORIGINATOR ADALIMUMAB IN NON-INFECTIOUS INTERMEDIATE, POSTERIOR AND PAN-UVEITIS FROM A SOCIETAL PERSPECTIVE IN PORTUGAL
Oct 1, 2018, 00:00
10.1016/j.jval.2018.09.2671
https://www.valueinhealthjournal.com/article/S1098-3015(18)35973-4/fulltext
Title :
PSY96 - COST-EFFECTIVENESS OF ORIGINATOR ADALIMUMAB IN NON-INFECTIOUS INTERMEDIATE, POSTERIOR AND PAN-UVEITIS FROM A SOCIETAL PERSPECTIVE IN PORTUGAL
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(18)35973-4&doi=10.1016/j.jval.2018.09.2671
First page :
Section Title :
Open access? :
No
Section Order :
2026